Overview

Clindamycin to Reduce Preterm Birth in a Low Resource Setting

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Preterm birth has been linked to certain types of vaginal infections. The goal of this study is to determine if giving women pregnant between 13-20 weeks with an elavated vaginal pH(evidence of this type of infection)Oral Clindamycin(an antibiotic)will have a lower rate of preterm birth compared to women given a placebo(starch)
Phase:
Phase 4
Details
Lead Sponsor:
Christiana Care Health Services
Collaborators:
Jawaharlal Nehru Medical College
Thrasher Research Fund
Treatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate